Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04830410Not ApplicableCompleted

The Effects of Carbohydrates in Irritable Bowel Syndrome

Role: collaborator

NCT04910815Not ApplicableUnknown

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

Role: lead

NCT05718505Not ApplicableUnknown

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Role: lead

NCT04977063Not ApplicableCompleted

Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients

Role: lead

All 4 trials loaded